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Low birth weight (LBW) increases infant morbidity and mortality worldwide. One well-established
risk factor is maternal smoking. Environmental tobacco smoke (ETS) exposure has recently been
focused on as another potential risk factor. In this article, we review epidemiologic literature on the
effects of ETS on LBW and intrauterine growth retardation (IUGR), the cause of LBW related to
maternal smoking. As we consider the feasibility of modifying women's exposure, we focus our
discussion on workplace exposure to ETS. The workplace is particularly important to consider
because women of child-bearing age are present in the workplace in greater numbers now than
ever before. In addition, certain subgroups of working women may be particularly at risk from the
effects of ETS on pregnancy because they work in environments with higher exposure or they are
more susceptible to its effects. We conclude that there is consistent evidence to relate maternal
ETS exposure to an increased risk of adverse pregnancy outcomes and that this association may be
generalized to the work environment. In studies with positive findings, infants exposed to ETS
antenatally were 1.5-4 times more likely to be born with LBW, but few studies examined LBW.
Most studies looked at measures of IUGR. ETS was associated with reductions in birth weight
(adjusted for gestational age) ranging from 25 to 90 g. Infants born to women exposed to ETS were
generally 2-4 times more likely to be born small-for-gestational age. ETS exposure in the workplace
can and should be minimized to protect pregnant women from its adverse effects. Key words: birth
weight, cotinine, environmental tobacco smoke, intrauterine growth retardation, low birth weight,
nicotine, passive smoke, pregnancy, small for gestational age, smoking, women, workplace.
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Low birth weight ([LBW] < 2500 g) is the
leading cause of infant mortality in the
United States. Approximately 7.4% of all
births in 1995 were LBW, a proportion that
has changed little in the past two decades (1).
Smoking is one ofthe few modifiable risk fac-
tors for LBW. There is an abundance ofevi-
dence linking maternal smoking to LBW
with relative risk estimates in the range of
2-4 (2). Two unfavorable birth outcomes,
not mutually exclusive, result in low birth
weight: preterm delivery and intrauterine
growth retardation (IUGR). The adverse
effects of maternal smoking on LBW appear
to operate through an effect on IUGR rather
than through an effect on preterm delivery.
Maternal smoking has consistently been
demonstrated to increase the riskofIUGRand
to reduce mean birth weight by approximately
150-250 g (2). There is a dose-response rela-
tionship between maternal smoking and
adverse pregnancy outcomes with a stepwise
increase in risk with an increased number of
cigarettes smoked per day (2). However, the
timing of the exposure (maternal smoking)
influences its effects on pregnancy outcomes.
The adverse effects on LBW and IUGR are
largely limited to smoking in the second half
ofpregnancy; women who quit smoking by
the second halfofpregnancy do not have an
increased risk of poor outcomes (3-5). The
biologic mechanism by which maternal
smoking causes growth retardation has not
been definitely established. The current evi-
dence suggests that the impairment ofgrowth
associated with maternal smoking results
from reduced oxygen flow to the fetus. The
maternal blood supply to the placenta is
reduced and its oxygen load attenuated by the
increased maternal carboxyhemoglobin levels
associated with maternal smoking (2,6). This
association between maternal smoking and
LBW fulfills many of the causal criteria
(strength of association, consistency, dose
response, reversibility, and biologic plausibil-
ity) and has been judged to be causal in the
Surgeon General's report (3).
The weight ofevidence linking maternal
smoking with LBW has led to concern about
the effects ofenvironmental tobacco smoke
(ETS). In addition, many ofthe chemicals in
cigarette smoke, including nicotine and car-
bon monoxide, are present in higher concen-
trations in undiluted sidestream smoke than
in the (mainstream) smoke inhaled by the
smoker (7,8). Of course, ETS comprises
diluted sidestream smoke and exhaled main-
stream smoke. Early studies (1960s) reported
small effects on birth weight associated with
in utero exposure to paternal smoking among
nonsmoking mothers (9,10). These studies
were limited in their ability to assess exposure
and to control for potential confounders.
Beginning in the 1980s, as effects ofETS on
children were recognized, there has been
renewed interest in this issue. Studies ofETS
and pregnancy outcomes have generally con-
tinued to be based on a woman's report of
ETS exposures, although sources of ETS
other than the father's smoking have been
considered. Recently, a few studies have
incorporated biomarkers ofexposure, either
cotinine (a nicotine metabolite) or nicotine
levels in the pregnant or postpartum woman.
ETS exposure in pregnant women increases
levels of nicotine and cotinine in pregnant
women and in their amniotic fluid (11,12).
In most studies ofETS and pregnancy, birth
weight adjusted for gestational age (a proxy
for IUGR) or birth weight alone has been the
focus with LBW itselfless frequently exam-
ined. Based on the studies ofmaternal smok-
ing, IUGR (assessed by small-for-gestational
age [SGA] [e.g., < 5th or < 10th percentile of
birth weight for gestation, > 2 SD (standard
deviation) below the mean birth weight for
gestation] or birth weight adjusted for gesta-
tional age) and LBW are indeed the most
appropriate outcomes to consider.
Review of ETS-LBW Literature
A review of the published literature on the
relationship between ETS and LBW, birth
weight, and IUGR (Table 1) was completed
using the MEDLINE database (National
Library ofMedicine, Bethesda, MD) through
1998 and the bibliographies of individual
papers. We a priori defined criteria for inclu-
sion ofa study to synthesize the current state
ofknowledge. These criteria were applied to
all studies regardless oftheir findings. Studies
were excluded if they did not a) describe
clearly how the exposure to ETS was deter-
mined (no such studies in fact were found);
b) clearly separate active smokers exposed to
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ETS from nonsmokers exposed to ETS (13);
c) consider potential confounders such as
socioeconomic status (14-18), birth weight
analysis only (19); d) provide no assessment
ofstatistical significance (10,15,17,20,21); or
e) characterize the studypopulation (21,22).
Recent studies ofETS generally show an
adverse effect of exposure on LBW, birth
weight, and IUGR, although as would be
expected, the effect sizes are smaller than for
maternal smoking. Even in those studies in
which the effects were not statistically signifi-
cant, ETS was consistently associated with
small effects in the direction ofincreased risks
for adverse outcomes (reductions in birth
weight, increases in risk ofLBWor IUGR).
Studies ofETS exposure and birth weight
fall into two groups: birth weight adjusted for
gestational age (23-30) or birth weight unad-
justed for gestational age (31-33). Obviously
the difference in birth weight will be larger if
birth weight is not adjusted for gestational
age. More important, when birth weight is
adjusted for gestational age, this parameter
becomes an estimate of fetal growth as it
relates size (weight) with time (gestational
age). Without adjusting for gestational age,
we cannot determine whether birth weight is
reduced among women exposed to ETS as a
result ofgrowth restriction or ifit is the result
of early delivery. Given that the effects of
maternal smoking appear to relate only to
growth restriction and not to preterm deliv-
ery (2,34), we expect a similar effect ofETS
exposure, although it is possible that the
mechanisms of effect might differ.
Furthermore, because study samples often
differ in their gestational age distributions, a
failure to adjust for gestational age could
result in different estimates ofthe effects of
ETS across studies. For this reason alone, the
literature may appear inconsistent.
In 4 ofthe 11 studies examining the effect
on birth weight (adjusted and unadjusted for
gestational age), the reductions in birth
weight were statistically significant (Figure 1,
Table 1). Although not all ofthe differences
in mean birth weight were statistically signifi-
cant, the estimates ofthe difference in mean
birth weights for 10 of the 11 studies were
negative, falling between -25 and -125 g. In
the three studies (31-33) that examined ETS
effects on birth weight unadjusted for gesta-
tional age, the effects ofETS were very simi-
lar, with point estimates clustering around
-105 g. When adjusting for gestational age,
the size of the effect was smaller and more
variable, ranging between -25 and -87 g. A
recently published meta-analysis (23) calcu-
lated average birth weight decrements associ-
ated with ETS exposure in nonsmoking
mothers. Based on studies that adjusted for
confounders, the pooled birth weight differ-
ence was -28.5 g (95% confidence interval
[CI]: -40.8, -16.2). Limiting themeta-analy-
sis to those studies that considered multiple
sources of ETS exposure and adjusted for
confounders, the pooled birth weight differ-
ence was -24 g (95% CI: -39.3, -8.6) (23).
Both ofthese estimates of the birth weight
difference are statistically significant.
Although this difference in birthweight is not
large and may not be clinically significant for
any individual infant, the birth weight distri-
bution is shifted down with exposure to ETS.
Such a shift on a population level would lead
to increases in LBW, a significant effect of
ETS for the population. It is unclear whether
the meta-analysis was limited to studies that
adjusted forgestational age.
IUGR can be examined using either a
continuous measure, such as birth weight
adjusted forgestational age, or a dichotomous
measure, such as SGA (< 5th or < 10th per-
centile ofbirth weight for gestational age, > 2
SD below mean birth weight for gestational
age). Many of the studies described in the
preceding paragraph and in Figure 1 are in
essence studies ofIUGR, as birth weight is
adjusted for gestational age. In three
(24,25,28) ofthe eight studies that examined
ETS effects on birth weight adjusted for ges-
tational age, the effect was statistically signifi-
cant (Figure 1, Table 1). In two (30,35) of
the five studies with nonsignificant effects of
ETS on birth weight, the sample ofbirths was
restricted to term (> 37 week) deliveries. The
effect on birth weight ofany exposure is usu-
ally smaller when restricted to this pool of
deliveries, as there is less variability in birth
weight after 37 weeks gestation. The point
estimates of the difference in mean birth
weights for all eight ofthe studies were nega-
tive, with the point estimates ranging
between -25 and-90 g.
Another less frequently used continuous
estimator ofIUGR is the birth weight ratio.
*
I
Rubin (33)*
Campbell (31)*
Haddow (32)*
Rebagliato (24)
Matthai (25)
Lazzaroni (26)
Eskenazi (27)
Martinez (28)
Zhang (29)
Martin (30)
Windham (23)
-300.0 -200.0 -100.0 0.0
Difference in mean birth weight(g)
Figure 1. Difference in mean birth weight related to
environmental tobacco smoke exposure. Studies labeled
by first author as given in Table 1. Studies with an aster-
isk (*) are notadjusted forgestational age.
The numerator is the birth weight observed
at agiven gestational age, and the denomina-
tor is the birthweightexpected at agiven ges-
tational age (the mean birthweight). Brooke
and colleagues (36) examined the effect of
ETS on this birth weight ratio measure and
found no significant difference in the birth
weight ratio related to ETS. Thisstudy is dif-
ficult to place in context because its methods
arequite different from those ofother studies
in this area; in particular, the birth weight
ratio is not a widely accepted estimator of
growth retardation.
Four studies examined the effect ofETS
on IUGR, using dichotomous measures of
SGA(Figure 2, Table 1). Two (37,38) ofthe
four studies reported strong (relative risk
estimates 3-4) and statistically significant
associations, notably one ofwhich used a bio-
marker for exposure (38). The effects ofETS
on LBW (a dichotomous variable) have also
been less often studied than the effects on
birth weight measured as a continuous vari-
able (Figure 3, Table 1). In three (19,30,39)
ofthe six studies, the odds ofLBW were sig-
nificantly and substantially increased for
infants born to women exposed to ETS,
although in two ofthe studies the significant
effect was only in a subgroup ofthe women
[women over 30 years ofage (39), nonwhite
women (19)]. Three ofthe studies examined
LBWonly in term infants or in term infants
separately (23,30,35); this is a subset ofLBW
thatoverlaps with IUGR. (Infants born LBW
at term are by definition SGA and growth
retarded.) The risk of a LBW infant at term
was increased in two studies (23,30), albeit
significant at =0.05 for only the Martin and
Bracken study (30). Overall, considering
findings for both LBW and LBW at term,
relative risk estimates for five ofthe sixstudies
showed an increase in risk. The meta-analysis
byWindham et al. (23) adds further evidence
Chen (62)
Fortier(52)(1-14hr/wk)
Fortier(52)(15-34hr/wk)
Fortier(52) (>35hr/wk)
Nafstad (38) (4th quartile)
Nafstad(38) (2nd &3rd quartiles)
Dejin-Karlsson (37)
3.0 ioo.o -3.0 -2.0 -1.0 0.0 1.0 2.0
In (RR)
Figure 2. The natural logarithm of the relative risk
estimates for small-for-gestational age related to envi-
ronmental tobacco smoke exposure. Studies labeled by
first author asgiven in Table 1.
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as given in Table 1. St
represent LBW at term
'W. The pooled odds ratio tutes and are easier to obtain (41). Nicotine
lies of LBW that adjusted in bodily fluids alone has a very short half-life
s was 1.38 (95% CI: (- 2-3 hr) and therefore can measure only
the most acute exposures (41). However,
nicotine levels assessed in hair do not have
this same limitation and nicotine levels in
e method of determining hair reflect tobacco smoke exposure over the
iay account for some ofthe past few months (43-46). A biomarker
ong these studies; they may assessment of ETS may also be more valid
h studies' results are more than self-reported exposure because it can
ng a conclusion about the account for differences in exposure not cap-
any of the studies relied on tured by reporting the number of hours one
;s exposure to ETS. Use of is exposed to ETS. For example, differences
res rather than biomarkers in ventilation of the environment can affect
rential or nondifferential the biologic burden received and would be
Nondifferential misclassifi- ignored by a self-reported assessment ofexpo-
tenuate real associations sure. Compared to self-report, differential
birth outcomes. Ifexposure misclassification would be much less likely
Lnderestimated using self- and nondifferential misclassification also rela-
,attentuation of the associ- tively less likely. However, biomarkers inte-
5 and birth outcomes could grate all sources of exposure and cannot
o more difficult to compare separate different sources. Self-reported
)sure across studies, as the assessment is crucial if one wishes to study
gories were rarely similar. effects of exposure by specific source (e.g.,
studies have used either home, workplace).
or both biomarkers and Among the four studies that used biologic
e, primarily two biomarkers measurements rather than self-report, three
been assessed in pregnant reported significant associations with adverse
a nicotine metabolite; and pregnancy outcomes. Nafstad et al. (38)
onent of cigarette smoke. found a significant increased risk of SGA
have established cotinine (growth retardation) associated with high
lid biomarkers for maternal nicotine levels in hair, categorized in quar-
tg (40-42). It should be tiles, in nonsmokers. Rebagliato et al. (24)
iat bodily fluid (e.g., blood, found a significant reduction in birth weight,
nine levels reflect exposure adjusted for gestational age, associated with
r period (half-life - 17 hr) high cotinine levels, also categorized in quin-
not capture chronic expo- tiles, in nonsmokers. This is consistent with
1). Blood levels ofnicotine the findings of Haddow et al. (32) who
Lrate proxy for the dose of reported that high serum cotinine levels in
ed from ETS exposure. nonsmokers were associated with significantly
;tudies of ETS have used decreased birth weight adjusted for gesta-
ncentrations because these tional age. Eskenazi et al. (27) also used
l found to be valid substi- serum cotinine, classified dichotomously
(2-10 ng/mL vs < 2 ng/mL) to assess ETS
exposure but found no significant effect on
Ahluwalia(39)(<30yrold) the outcome. The dichotomous categoriza-
hawa(35)* tion in the Eskenazi et al. study (27) may
W-ndham(23) have also diluted a real effect ofhigher level
* wn o exposures by including possibly hazardous
Ahlborg147)(ETSwork, no ETSwork) Ahor lower level exposures with the reference group Mainous(19) (< 2 ng/mL). The reference groups for the
_Ahlborg(47)(ET worklanepregnancy) cotinine studies reporting significant adverse
Windham(23)* effects [Rebagliato et al. (24) and Haddow
Martin(30)* et al. (32)] were restricted to the lowest levels
Mainous(19)(nonwhites) ofcotinine (0-0.5 ng/mL). Statistical power
Ahluwalia(39)(>3yrold) may have been limited in the study by
Eskenazi et al. (27), as only 5.1% of non-
0.0 1.0 2.0 smokers were classified as exposed to ETS
In (RR) based on cotinine levels (2-10ng/mL). This
is in contrast to the Rebagliato et al. study
1weight related to environmental (24) in which the prevalence of exposure in
re. Studies labeled byfirst author the highest quintile was nearly 20% (1.8-14
tudies marked with an asterisk (*) ng/mL) and the Haddow et al. study (32) in
ionly. which prevalence ofexposure to ETS based
on cotinine was 31.4% (1-9.99 ng/mL). The
upper levels for the studies ofRebagliato et al.
and Eskenazi et al. also differ, with Eskenazi
et al. (27) excluding women with levels over
10 ng/mL and Rebagliato et al. (24) exclud-
ing those over 14 ng/mL as possibly active
smokers. The exclusion of women in the
10-14 ng/mL range may also have con-
tributed to the smaller effect size seen in the
Eskenazi et al. study (27) compared to the
Rebagliato et al. study (24).
Critical Period ofExposure
The timing ofthe ETS exposure is an impor-
tant issue addressed explicitly by only one of
the studies. Studies of maternal smoking in
pregnancy have consistently shown that it is
only smoking in the second halfofpregnancy
that exerts a significantly adverse effect on
LBW, IUGR, and birth weight (4,5).
Therefore, one might also expect ETS expo-
sures limited to the first half of pregnancy to
exert little or no effect. Failure to separate
early and late exposures might dilute the esti-
mated effects. There is reason to expect that
ETS exposures might change over the course
of pregnancy, particularly ETS exposure in
the workplace. Women may stop working as
their pregnancy progresses and partners and
co-workers might reduce their smoking
around a woman as she becomes visibly preg-
nant. Nonsmoking pregnant women might
become more active in their attempts to
reduce ETS exposures as their pregnancy pro-
gresses. The one study (47) that explicitly
examined ETS in late pregnancy found an
increased risk of LBW, albeit not significant,
ofworkplace ETS exposure in later pregnancy
(OR = 1.83) but no substantial increase in
risk for workplace ETS exposure overall
(OR = 1.21). Although the other studies
reviewed did not explicitly examine ETS
exposures by gestation, the questions and
timing of interviews and/or biomarker assess-
ment offer some clues. Nearly all the inter-
view studies asked women about their
exposures generally during pregnancy and did
not specify the time period ofinterest. In two
studies, those by Ahluwalia et al. (39) and
Martin and Bracken (30), the questions were
asked at the first prenatal visit. Neither article
provides information on the mean gestational
age at first visit. However, even with low
income populations in the United States,
which comprised the study population, most
women obtaining prenatal care do so before
the 20th week of pregnancy. A study con-
ducted in Sweden (37) also asked about ETS
at the first prenatal visit and noted that the
mean gestational age at first visit was 12
weeks. Therefore, these three studies presum-
ably assessed ETS exposure in the first halfof
pregnancy. The Haddow et al. study (32)
relied on serum cotinine measured in the
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second trimester and also presumably assessed
exposure in the first halfofpregnancy. All
these studies found strong adverse effects of
ETS that might suggest that exposure to ETS
did not change during pregnancy. The
Martinez et al. study (28), which interviewed
families postnatally about paternal smoking
and ETS assessment, would be expected to
represent the entire pregnancy with a possible
bias toward representing exposure in the lat-
ter part ofpregnancy due to length ofrecall.
In this study, astatisticallysignificant trend of
decreasing birth weight with increasing expo-
sure dose was reported. Two ofthe studies
employing biomarkers collected their samples
in the third trimester: Eskenazi et al. (27)
analyzed cotinine from samples collected at
27-28 weeks gestation and Rebagliato et al.
(24) analyzed cotinine from samples col-
lected in the third trimester. The Eskenazi et
al. study (27) reported no significant associa-
tion between high levels ofcotinine and birth
weight, whereas the Rebagliato et al. study
(24) found a significant reduction in birth
weight associated with similar levels ofcoti-
nine. Nafstad et al. (38) collected hair sam-
ples for nicotine analysis in the immediate
postpartum period, which would represent
the few months of exposure. Presumably,
then, the measure ofETS in the Nafstad et al.
study (38) would capture exposure in the last
trimester ofpregnancy. As noted above, this
study did find a strong association between
nicotine level and riskofSGA.
OutcomeMeasure
The choice of outcome measure is also
important to consider. Overall, there appear
to be stronger effects of ETS on LBW and
SGA than on birth weight (adjusted or not
for gestational age). This difference is infor-
mative and may help us to understand how
ETS exposure acts. The discrepancies in find-
ings suggest that the reduction in birth
weight is not uniform across the full distribu-
tion ofbirth weight. A uniform reduction in
birth weight across the distribution ofbirth
weight would result in some increase in LBW
or SGA. The size ofthe effect ofETS expo-
sure on LBW and SGA is often large, how-
ever, with ORs of2 or greater. This effect is
more similar to effects seen for maternal
smoking during pregnancy, whereas the birth
weight effects are much smaller than those for
maternal smoking. Perhaps the reduction in
birth weight is larger for infants at the lower
end of the birth weight distribution. Martin
and Bracken (30) also observe that while the
decrease in birth weight is relatively small
compared to that ofdirect maternal smoking,
the reduction "appears to operate on the low
end ofthe birth weight distribution, thereby
increasing risk" of LBW. Perhaps infants
born in the lower end of the birth weight
distribution are more likely to be exposed to
ETS, and several studies have previously
demonstrated that women oflow socioeco-
nomic status are at increased risk for LBW
(48). The stronger effect of ETS on LBW
compared to birth weight is also important
with regard to infant outcomes. Although
reductions in birth weight are associated with
increases in infant mortality across the entire
birth weight continuum, reductions in birth
weight that lead to LBW are much more haz-
ardous. Approximately two-thirds of all
infants deaths in the United States in 1995
occurred to infants born with LBW (1).
Infants born with LBW are also more likely
to have neurodevelopmental problems such as
cerebral palsy (49). Therefore, the effects of
ETS on LBW are relatively more important
in terms ofpolicy than the effects ofETS on
birth weight alone.
Confounding
All these studies have considered the poten-
tial for confounding of the association
between exposure to ETS and birth out-
comes. In many ofthe studies, a wide range
ofcovariates have been included in the final
models to produce unconfounded estimates
ofeffect. The obvious potential confounders
have been considered. There is some risk,
however, that these studies may have con-
trolled for covariates that should not be con-
sidered confounders but rather are part of
the causal pathway. This may be particularly
true ofstudies considering ETS in the work-
place. ETS exposure may indeed be higher
in workplaces in which working conditions
are more strenuous. Increased ETS levels
may be the result of these working condi-
tions and controlling for them in the analy-
sis may remove the very real effects of ETS.
This is especially problematic with regard to
socioeconomic status. As stated earlier,
socioeconomic status is a very strong predic-
tor of LBW risk and also may be related to
ETS exposure. The higher ETS exposure
levels may be part ofthe explanation for the
increased risk of LBW to women of low
socioeconomic status. Therefore controlling
for socioeconomic status would mask a real
effect ofETS.
Stadstical Power
Given that the effect size is likely small and
the prevalence ofexposure may vary depend-
ing on the population, inadequate statistical
power to detect the effects may be a source of
inconsistency in the findings reported for
ETS and birth outcomes. The onlyone ofthe
four studies using a biomarker that did not
find a significant effect of ETS had an
extremely low rate ofexposure (less than 10%
ofwomen were classified as exposed based on
the cotinine levels in the Eskenazi study).
Discussion
LBWincreases infant morbidityand mortality
worldwide. One well-established risk factor is
maternal smoking. ETS exposure has recently
been focused on as another potential risk fac-
tor. As we consider the feasibility ofmodify-
ing women's exposure, we have focused our
discussion on workplace exposure to ETS.
The workplace is particularly important to
consider because women ofchild-bearing age
are present in the workplace in greater num-
bers than ever before. In 1994 (the most
recent data available), there were 60 million
women in the U.S. labor force and those
women made up 46% ofthe total U.S. labor
force. Between the ages of 20 and 44, the
peak child-bearing years for women, labor
force participation rates exceeded 70% for
women (50). In addition, certain subgroups
ofworking women may be particularly at risk
from the effects ofETS on pregnancy because
they work in environments with higher expo-
sure or are more susceptible to its effects. In
1994, 10 million American women worked
in the service industry, 4.3 million worked as
machine operators, fabricators, or laborers,
and 1.2 million worked in precision produc-
tion, craft or repair trades (50), workplaces in
which ETS maystill be a problem.
This discussion evaluates the charges
given to the participants in the July 1998
U.S. Occupational Safety and Health
Administration workshop on ETS in the
workplace and health outcomes. Three spe-
cific charges were given in the area of low
birthweight: (1A) "What is the dose-response
relationship for ETS exposure and LBW?";
(1B) "Are exposures in the workplace in a
range ofbiologic concern?"; (2) "Are there
studies ofoccupational exposure to ETS and
LBW?"; (3) "Can results from studies ofbirth
weight and ETS exposure generally be
extended to the workplace?".
Char 1AA WhatIstheDose-Response
RelationshipforETSExposure
andLBW?
A critical examination ofstudies done to date
and with greater weight placed on studies
with fewer methodologic limitations leads
this reviewer to conclude that there is a con-
sistent and plausible association between ETS
and LBW. The recent meta-analysis and
qualitative literature review by Windham
et al. (23) also comes to the same conclusion,
suggesting an average increase in LBW of
approximately 38%. In response to the first
part of this charge, determination of a
dose-response effect, the evidence is some-
what weaker. Few of the studies published
appear to have examined this issue. However,
unless ETS exposure influences birth weight
through a different mechanism than does
maternal smoking, we would expect a
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dose-response pattern similar to what is
found for maternal smoking exposure. A
caveat to this is that ETS exposures might be
constrained to such a limited and low level as
to make dose-response effects too subtle to
detect and perhaps even of little relevance.
Only five ofthe studies with positive findings
(statistically significant associations ofETS
exposure with birth outcomes) collected and
analyzed the ETS exposure data in such away
as to examine the possibility ofdose-response
patterns. Both studies using interview data
(28,33) and one study using biomarkers of
exposure data (24) found some evidence ofa
dose-response trend.
Charge 1B:AreExposures inthe
Workplace inaRange ofBiologic
Concern?
To respond to the latter part of the first
charge, we need information on workplace
ETS exposure levels for pregnant women.
Although most studies report ETS exposure as
the number ofhours ofexposure per day, we
can only consider these data as surrogates for
exposure levels (51). To determine ifwork-
place exposures are in a range associated with
risk, we would need studies that measure bio-
marker levels in pregnant women as proxies
for levels ofETS in the workplace. The most
appropriate biomarker of ETS exposure for
pregnant women is not certain, as it is unclear
which components of cigarette smoke are
responsible for the reduction in fetal growth.
Nicotine and carbon monoxide are the two
components best established as relating to the
adverse effect ofmaternal smoking. In terms
ofbiomarkers, the best established for use in
studies ofETS and pregnancy are nicotine
and its metabolite, cotinine. Measures ofcar-
bon monoxide have not been used in studies
of pregnant women. Benowitz (41), in a
review ofthe validity ofcotinine as an ETS
biomarker, argues that carbon monoxide in
the blood is a nonspecific and insensitive
marker ofETS exposure. Therefore, although
the effects of ETS may operate in part
through carbon monoxide, carbon monoxide
may be problematic as a best biomarker of
ETS exposure in pregnancy.
To establish whether levels of ETS
exposure in the workplace are hazardous, we
need to first determine what level ofcotinine
or nicotine, the two relevant biomarkers, rep-
resents a hazardous level of exposure for a
pregnant woman. Based on the studies using
cotinine as a biomarker, it appears that
adverse effects are most likely reached when
cotinine levels exceed 1.7 ng/mL, although
they may be reached at lower levels. Studies
ofself-reported ETS exposure that considered
dose-response effects do not provide consis-
tent guidance. Even ifwe can reach a conclu-
sion about what level is hazardous, we must
then determine whether the workplace can
produce levels of this magnitude. Studies
would be needed of nonsmoking pregnant
women exposed to ETS only in the work-
place. In these studies, cotinine or nicotine
levels could be measured across a variety of
workplace environments. Furthermore, the
fetus may be more or less susceptible to a
given level ofETS absorbed by the mother
(measured as cotinine or nicotine) due to dif-
ferences in placental hemodynamics or other
interactions with the maternal-uterine-pla-
cental environment. Given these challenges,
the two most feasible approaches to protect
pregnant women would be to either a) rely
on standards developed for nonpregnant
adults with regard to health outcomes for
which more data are available; or b) assume
all ETS exposure is unsafe for pregnant
women, as the data from two ofthe best and
most recent studies (24,32) indicate that even
low levels ofmaternal cotinine (1-2 ng/mL)
are hazardous.
Charge 2:AreThereStudies of
OccupationalExposure to ETS
andLBW?
There are two primary sources of ETS
exposure for pregnant women: exposure in
the home and exposure in the workplace.
Self-reported measures ofETS exposure can
separate home from workplace exposures.
Biologic measures ofETS exposure integrate
all sources of ETS exposure (home, work,
public spaces) as well as maternal smoking
exposure (unless women who smoke are
excluded). Therefore studies that relied on
biomarkers alone cannot differentiate the
effects ofoccupational exposure from other
sources ofETS exposure. In the studies that
included self-reported measures, only two
separated occupational exposure to ETS from
other ETS exposure (47,52). It is worth not-
ing that in both these studies, exposure in the
home alone did not appear to have adverse
effects on pregnancy; but there were effects,
albeit small effects, ofexposure in the work-
place alone. One ofthe two studies (52) also
showed a dose-response trend, with an
increasing risk ofa SGA infant being born as
the number of hours ofworkplace ETS
exposure increased.
Charge 3: Can Results fromStudies
ofBirthWeightandETSExposure
GenerailyBeExtendedtothe
Workplace?
There are no obvious reasons why such
studies could not be generalized. The poten-
tial for interactions between ETS and other
workplace exposures is the primary factor that
would complicate extrapolations of nonoccu-
pational studies. It may be that there are
workplace exposures that act synergistically to
magnify the effect of ETS on birth weight.
These exposures could be other airborne
pollutants as well as any of a number of
chemical exposures in the workplace. Stress,
physical or psychologic, is another factor
that could interact with ETS exposure to
increase the adverse effects on birth weight.
There is one important interaction that has
been examined in past studies that may be
particularly relevant to pregnant workers
and that is the interaction between smoking
and maternal age. One study of ETS (39)
has shown an interaction between maternal
age and ETS exposure such that ETS more
than doubled the risk of LBW (OR = 2.4;
95% CI = 1.5, 3.9) for older women (30
years of age) while having no adverse effect
on outcomes for younger women (OR = 0.9;
95% CI = 0.8, 1.1). These data are not
inconsistent with studies of maternal smok-
ing that show adverse effects for women of
all ages but find stronger effects among older
women (53). As U.S. women increasingly
choose to delay their first birth (54), this
interaction may be very important to consider
when establishing policies.
Poverty might also act to enhance the risk
ofETS exposure. Poorwomen are avulnerable
population with regard to adverse pregnancy
outcomes. Women oflower socioeconomic
status have lower mean birth weights and
higher rates ofLBW, IUGR, and infant mor-
tality (55-58). As discussed earlier, the effect
ofETS on birth weight may not be uniform
across the birth weight continuum. Even ifthe
effect is uniform, the lower mean birth weight
for poor women implies that additional
adverse exposures might push birth weight
into the more dangerous LBW range. In the
workplace, poor women are more likely to
hold jobs in which exposure levels are higher
(such as in the service industry or in factories)
and to be inworkplaces in which theyhave lit-
tle power to ask for environmental modifica-
tions. Poor women are more likely than other
women to be undocumented workers, and
whether or notlegal residents, poorwomen are
more likely to work in unregulated work envi-
ronments such as garment sweatshops. With
the enactment ofthe Personal Responsibility
and Work Opportunity Reconciliation Act of
1996 (59) (also referred to as TANF,
Temporary Assistance to Needy Families),
more pregnant women from these disadvan-
taged groups will be in the workplace with lit-
tle or no control over theirworking conditions
except forgovernment regulations (60). For all
these reasons, ETS exposure is an issue ofpar-
ticular concern with regard to pregnancy out-
comes in this population. Poor women are also
more likely to be smokers themselves (61) and
may be more likely to be exposed to other
substances or conditions that increase the risk
ofLBW.
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Conclusion
In summary, ETS exposure appears to have
adverse effects on fetal growth parallel to
what is seen for maternal smoking, but, as
would be expected with less exposure, effects
are generally smaller than those for maternal
smoking. As a consequence, morbidity and
mortality would be expected to be higher for
infants born to women exposed to ETS dur-
ing pregnancy. The workplace is one source
of exposure to ETS for pregnant women
that can and should be minimized to reduce
risk of adverse pregnancy outcomes for
working women.
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